Aktie 300937 SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Aktien

300937

CNE100004CV9

300937

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
22,64 CNY -0,75 % Intraday Chart für Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. -6,10 % -28,01 %
24.04. Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
09.04. Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2024.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Sichuan Zhonghuisheng Traditional Chinese Medicine Material partnership (limited partnership) agreed to acquire 80% stake in Sichuan Hezong Traditional Chinese Medicine Pieces Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 6.7 million.
Sichuan Hezong Medicine Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable 22 May 2023
Sichuan Hezong Medicine Co., Ltd. Approves Cash Dividend for 2022
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Hezong Medicine Easy-to-Buy Pharma to Apply For Up to 500 Million Yuan Bank Loan
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Li Yuemin agreed to acquire additional 58.02% stake in Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 15.4 million.
Hezong Medicine Chairman Boosts Stake to 55% After 230 Million Yuan Deal
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Announces Management Changes
Wuxu Data announced that it has received $0.3 million in funding from Sichuan Shenniao Century Technology Co., Ltd. and Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. and another investor
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2022.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300937 Aktie
  4. Nachrichten Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.
  5. Andere Sprachen